Search Results 1901-1910 of 14785 for anti-TNF drugs
See sample animations used as research tools in Mayo Clinic's Drug Discovery, Design and Optimization for Novel Therapeutics Lab in Florida.
Managing refractory edema in patients receiving palliative care - The goal of complex decongestive therapy is to normalize tissue volume and texture.
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
Mayo Clinic Sports Medicine Research, led by Michael J. Stuart, M.D., studies sports injury prevention and treatment and improving athletic performance.
- Subjects must be refractory or must have progressed on, or following discontinuation of the most recent anti-cancer therapy, with the following considerations ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aplisol; Tubersol. Descriptions. Tuberculin ...
Have previously been treated with anti-HER2 targeting therapy. Have received treatment with any systemic anticancer therapy (including hormonal and biologic ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Symtuza. Descriptions. Darunavir, cobicistat ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Iodopen. Descriptions. Sodium iodide is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.